← Eichor
Study identifier: NCT05963126 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients

Condition: Arterial Hypertension  ·  Sponsor: University Hospital Ostrava

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Commonly used parameters (creatinine, estimated glomerular filtration rate, and urine albumin/creatinine ratio) for prediction of decline of renal function are sensitive for advanced kidney impairment. Modified human urine Fetuin A (urine Fetuin A) with specific modification in urine (Fetuin A) can earlier predict the progression of kidney disease in patients with diabetes. Studies evaluating urine Fetuin A in hypertonic patients are still lacking.

This description comes directly from the study's public registry record.

Talk to the study team

Jiří Hynčica  ·  0042059737  ·  jiri.hyncica@fno.cz

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Ostrava, - Department of Internal Medicine and CardiologyOstrava, Czech Republic, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05963126